![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
S Consolo, S Arnaboldi, S Ramponi, L Nannini, H Ladinsky and G Baldi
Laboratory of Cholinergic Neuropharmacology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
We characterized the role of endogenous serotonin (5-HT) in regulating in vivo acetylcholine (ACh) output in frontal cortex of freely moving rats using the microdialysis technique. Systemic (0.63, 1.25 and 2.5 mg/kg, i.p.) or local (20 and 40 microM, reverse dialysis) administration of the 5-HT releaser and uptake inhibitor, d- norfenfluramine, dose-dependently enhanced frontal cortex ACh output. The d-norfenfluramine-induced increase in cortical ACh release was tetrodotoxin sensitive and completely prevented by a 7-day chemical degeneration of the serotonergic afferents to the frontal cortex. Investigating the 5-HT receptors that might mediate the d- norfenfluramine cholinergic effect, we found that the 5-HT4 (GR 125487) and 5-HT2A/2C (ritanserin) receptor antagonists, at doses effective in other in vivo tests, did not prevent the increase in cortical ACh output induced by the maximal effective does of d-norfenfluramine. However, the 5-HT1A/1B receptor antagonists (-)-pindolol (8 mg/kg, s.c.) or (-)-propanolol (8.8 mg/kg, i.p.) antagonized the increasing effect of d-norfenfluramine although the selective 5-HT1A receptor antagonist WAY-100635 (1 and 2 mg/kg, s.c.) did not. In accordance with an involvement of the 5-HT1B receptor in the ACh facilitation induced by d-norfenfluramine is the finding that the selective 5-HT1B agonist, CP-93,129, given locally (2, 4 and 8 micrograms/side) does-dependently raised cortical ACh release. In conclusion, the overall regulatory control exerted by endogenous 5-HT in vivo is to facilitate frontal cortex ACh release through 5-HT1B receptors located in the frontal cortex. The 5-HT1B receptors may act indirectly to facilitate ACh release probably by inhibiting cortical inhibitory inputs onto the cholinergic neurons.
This article has been cited by other articles:
|
|
 |
|
  K. B. Fink and M. Gothert 5-HT Receptor Regulation of Neurotransmitter Release Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Buhot, M. Wolff, N. Benhassine, P. Costet, R. Hen, and L. Segu Spatial Learning in the 5-HT1B Receptor Knockout Mouse: Selective Facilitation/Impairment Depending on the Cognitive Demand Learn. Mem., November 1, 2003; 10(6): 466 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wolff, N. Benhassine, P. Costet, R. Hen, L. Segu, and M.-C. Buhot Delay-Dependent Working Memory Impairment in Young-Adult and Aged 5-HT1BKO Mice as Assessed in a Radial-Arm Water Maze Learn. Mem., September 1, 2003; 10(5): 401 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Mayorga, A. Dalvi, M. E. Page, S. Zimov-Levinson, R. Hen, and I. Lucki Antidepressant-Like Behavioral Effects in 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B Receptor Mutant Mice J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1101 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Giovannini, I. Ceccarelli, B. Molinari, M. Cecchi, J. Goldfarb, and P. Blandina Serotonergic Modulation of Acetylcholine Release from Cortex of Freely Moving Rats J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1219 - 1225. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
